Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Hospital IT

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1856920

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1856920

Patient Safety and Risk Software Market by Function (Incident Reporting, Compliance, Clinical Safety, Claims Management), End User, Deployment, and Region - Global Forecasts to 2030

PUBLISHED:
PAGES: 337 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

List of Tables

The global patient safety and risk software market is projected to reach USD 2.99 billion by 2030 from USD 1.75 billion in 2025, at a high CAGR of 11.36% during the forecast period. The patient safety and risk software market is emerging as a critical priority for healthcare systems worldwide, aimed at minimizing medical errors and improving the quality of care. Its growth is being driven by rising incidences of adverse events, increasing complexity of healthcare delivery, and the push toward value-based care models.

Scope of the Report
Years Considered for the Study2024-2030
Base Year2024
Forecast Period2025-2030
Units ConsideredValue (USD billion)
SegmentsFunction, Deployment, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

Regulatory frameworks from bodies such as the FDA, EMA, and The Joint Commission mandate strict reporting, monitoring, and compliance, compelling providers and life sciences companies to adopt advanced PSRM solutions. At the same time, government initiatives, such as the US Department of Health and Human Services' patient safety programs and the EU's pharmacovigilance regulations, are accelerating adoption. However, barriers such as high implementation costs, lack of global standardization, integration challenges with legacy systems, and underreporting of safety events continue to limit widespread adoption.

Patient Safety and Risk Software Market - IMG1

Compliance & governance under the function segment is expected to register the fastest growth during the forecast period.

The compliance & governance segment is the fastest-growing segment during the forecast period, driven by the rising emphasis on meeting regulatory requirements and maintaining transparency in healthcare operations. Increasing scrutiny from regulatory bodies, coupled with the need for standardized reporting and audit trails, is encouraging healthcare organizations to adopt advanced compliance management solutions. These tools help ensure adherence to quality standards, data protection regulations, and patient safety protocols, thereby supporting risk mitigation and operational efficiency across the healthcare ecosystem.

The cloud-based deployment segment is projected to register the fastest growth during the forecast period.

The cloud-based segment is the fastest-growing segment, driven by the rising adoption of digital health technologies and the shift toward flexible, scalable deployment models. Cloud solutions offer seamless data access, interoperability, and real-time collaboration across healthcare settings, enabling faster decision-making and improved patient safety outcomes. Additionally, lower upfront costs, reduced IT infrastructure requirements, and enhanced data security through advanced encryption and compliance measures are further accelerating the adoption of cloud-based platforms in this market.

Asia Pacific is expected to witness the highest growth rate during the forecast period.

The Asia Pacific region is positioned to register the highest CAGR in the patient safety and risk software market, driven by unprecedented healthcare digitization, government initiatives, and substantial technology investments. For example, the smart hospital program in China aims to upgrade over 1,000 public hospitals by 2025 with integrated IT solutions. The growing burden of medical errors, expansion of healthcare infrastructure, and the push for EHR/EMR integration across emerging economies such as India, China, and Southeast Asia are further fueling adoption. The expanding pharmaceutical and medical device sectors in the region, coupled with a rising patient population, are creating strong demand for efficient risk management and safety solutions.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below:

  • By Company Type - Tier 1: 31%, Tier 2: 28%, and Tier 3: 41%
  • By Designation - C Level: 31%, Director Level: 25%, and Others: 44%
  • By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players operating in the patient safety and risk software market include Riskonnect, Inc. (US), Origami Risk LLC (US), RLDatix (US), Health Catalyst (US), symplr (US), Clarity Group, Inc. (US), Performance Health Partners (US), MorCare, LLC (US), RiskQual Technologies, Inc. (US), Prista Corporation (US), IQVIA Inc. (US), Inovalon (US), NAVEX Global, Inc. (US), Censinet (US), American Data Network (US), Arventa Pty Ltd (Australia), ComplianceQuest (US), Radar Healthcare Inc (UK), Pascal Metrics Inc. (US), and SafeQual Health (US)

Research Coverage

The report analyzes the patient safety and risk software market and estimate the market size and future growth potential of various market segments, based on function, deployment mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a higher share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights into:

  • Analysis of key drivers (rising patient safety incidents, increasing prioritization of patient safety, escalating healthcare costs and shift toward value-based care models, increasing adoption of digital health technologies), restraints (high implementation and maintenance costs, resistance to adoption and perceived complexity of patient safety and risk software, data privacy and interoperability challenges), opportunities (growing adoption of AI, predictive analytics, and automation, increasing adoption of patient safety and risk software into MedTech and pharma safety domains, integration of patient safety and risk software with population health and real-world evidence platforms), challenges (lack of global standardization in safety reporting, complex integration with legacy systems, limited awareness and underreporting of safety incidents)
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and solution launches in the patient safety and risk software market.
  • Market Development: Comprehensive information on the lucrative emerging markets, function, deployment mode, end user, and region
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient safety and risk software market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient safety & risk software market such as Riskonnect, Inc. (US), Origami Risk LLC (US), RLDatix (US), symplr (US), and Radar Healthcare Inc (UK)
Show more
Product Code: HIT 7318

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS AND EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Insights from primary experts
  • 2.2 MARKET SIZE ESTIMATION
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
    • 2.4.1 MARKET SIZING ASSUMPTIONS
    • 2.4.2 OVERALL STUDY ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS
    • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.5.2 SCOPE-RELATED LIMITATIONS
  • 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 PATIENT SAFETY AND RISK SOFTWARE MARKET OVERVIEW
  • 4.2 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER AND REGION
  • 4.3 PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT
  • 4.4 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising patient safety incidents
      • 5.2.1.2 Increasing prioritization of patient safety
      • 5.2.1.3 Escalating healthcare costs and shift toward value-based care models
      • 5.2.1.4 Increasing adoption of digital health technologies
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High implementation and maintenance costs
      • 5.2.2.2 Resistance to adoption and perceived complexity of patient safety and risk software
      • 5.2.2.3 Data privacy and interoperability challenges
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing adoption of AI, predictive analytics, and automation
      • 5.2.3.2 Increasing adoption of patient safety and risk solutions into MedTech and pharma safety domains
      • 5.2.3.3 Integration of patient safety and risk software with population health and real-world evidence platforms
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of global standardization in safety reporting
      • 5.2.4.2 Complex integration with legacy systems
      • 5.2.4.3 Limited awareness and underreporting of safety events
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 MOBILE HEALTH PLATFORMS
    • 5.3.2 CLOUD-BASED ALARM MANAGEMENT SOLUTION
    • 5.3.3 IOT-ENABLED SOLUTIONS
  • 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
  • 5.5 PRICING ANALYSIS
    • 5.5.1 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER
    • 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION
  • 5.6 VALUE CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
  • 5.8 INVESTMENT AND FUNDING SCENARIO
  • 5.9 TECHNOLOGY ANALYSIS
    • 5.9.1 KEY TECHNOLOGIES
      • 5.9.1.1 AI-powered risk scoring
      • 5.9.1.2 Automated root cause analysis
      • 5.9.1.3 Real-time safety dashboards
      • 5.9.1.4 Mobile incident reporting apps
    • 5.9.2 ADJACENT TECHNOLOGIES
      • 5.9.2.1 Cloud SaaS platforms
      • 5.9.2.2 Blockchain
    • 5.9.3 COMPLEMENTARY TECHNOLOGIES
      • 5.9.3.1 EHR/EMR integration
      • 5.9.3.2 Claims and billing systems
      • 5.9.3.3 Credentialing systems
  • 5.10 PATENT ANALYSIS
    • 5.10.1 PATENT PUBLICATION TREND
    • 5.10.2 LIST OF PATENTS
  • 5.11 KEY CONFERENCES AND EVENTS, 2025-2027
  • 5.12 CASE STUDY ANALYSIS
    • 5.12.1 ADOPTION OF VIRTUAL OBSERVATION SOLUTION TO REDUCE FALL RATES IN PATIENTS
    • 5.12.2 UTILIZATION OF ENTERPRISE RISK MANAGEMENT SYSTEM FOR ENHANCED PATIENT SAFETY
    • 5.12.3 USE OF COMPREHENSIVE HEALTHCARE RISK MANAGEMENT SOFTWARE FOR IMPROVED REGULATORY COMPLIANCE
  • 5.13 REGULATORY LANDSCAPE
    • 5.13.1 REGULATORY ANALYSIS
    • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.14 PORTER'S FIVE FORCES ANALYSIS
    • 5.14.1 BARGAINING POWER OF SUPPLIERS
    • 5.14.2 BARGAINING POWER OF BUYERS
    • 5.14.3 THREAT OF NEW ENTRANTS
    • 5.14.4 THREAT OF SUBSTITUTES
    • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.15.2 BUYING CRITERIA
  • 5.16 END-USER ANALYSIS
    • 5.16.1 UNMET NEEDS
    • 5.16.2 END-USER EXPECTATIONS
  • 5.17 BUSINESS MODEL
    • 5.17.1 SUBSCRIPTION LICENSING
    • 5.17.2 MODULAR PLATFORM APPROACH
    • 5.17.3 IMPLEMENTATION AND INTEGRATION FEES
    • 5.17.4 VALUE-ADDED SERVICES
    • 5.17.5 MARKETPLACE INTEGRATION AND REGIONAL PRICING
  • 5.18 IMPACT OF AI/GEN AI ON PATIENT SAFETY AND RISK SOFTWARE MARKET
    • 5.18.1 INTRODUCTION
    • 5.18.2 TOP USE CASES AND MARKET POTENTIAL
    • 5.18.3 KEY USE CASES
    • 5.18.4 CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION
      • 5.18.4.1 Use of AI-powered data extraction platform with risk management software
    • 5.18.5 INTERCONNECTED AND ADJACENT ECOSYSTEMS
      • 5.18.5.1 Pharmacovigilance and drug safety monitoring
      • 5.18.5.2 Healthcare information exchange
      • 5.18.5.3 Quality improvement software
      • 5.18.5.4 Healthcare GRC
    • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
      • 5.18.6.1 Healthcare providers
      • 5.18.6.2 Pharmaceutical & biotechnology companies
  • 5.19 IMPACT OF 2025 US TARIFF
    • 5.19.1 INTRODUCTION
    • 5.19.2 KEY TARIFF RATES
    • 5.19.3 PRICE IMPACT ANALYSIS
    • 5.19.4 IMPACT ON COUNTRY/REGION
      • 5.19.4.1 US
      • 5.19.4.2 Europe
      • 5.19.4.3 Asia Pacific
    • 5.19.5 IMPACT ON END-USE INDUSTRIES

6 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION

  • 6.1 INTRODUCTION
  • 6.2 RISK & SAFETY MANAGEMENT
    • 6.2.1 INCIDENT REPORTING SYSTEMS
      • 6.2.1.1 Need for real-time reporting and automated workflows to support growth
    • 6.2.2 EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE
      • 6.2.2.1 Ability to analyze incident patterns and implement risk mitigation to promote growth
    • 6.2.3 PATIENT LEARNING SYSTEMS
      • 6.2.3.1 Increasing focus on improving patient safety to foster growth
  • 6.3 COMPLIANCE & GOVERNANCE
    • 6.3.1 RISK/COMPLIANCE MONITORING AND ANALYTICS SOFTWARE
      • 6.3.1.1 Evolving need for continuous surveillance of organizational activities to aid growth
    • 6.3.2 GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS
      • 6.3.2.1 Growing shift from reactive compliance management to proactive risk prevention to boost market
  • 6.4 CLINICAL SAFETY CONTROLS
    • 6.4.1 MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE
      • 6.4.1.1 Need to prevent medication errors to contribute to growth
    • 6.4.2 INFECTION CONTROL SYSTEMS
      • 6.4.2.1 Rise in proactive surveillance, rapid intervention, and continuous monitoring to expedite growth
  • 6.5 FINANCIAL & LEGAL RISK HANDLING
    • 6.5.1 CLAIMS MANAGEMENT SOLUTIONS
      • 6.5.1.1 Need to leverage data-driven claims management to minimize costs to favor growth
    • 6.5.2 REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS
      • 6.5.2.1 Growing focus on minimizing financial and legal risks to propel market

7 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE

  • 7.1 INTRODUCTION
  • 7.2 ON-PREMISE DEPLOYMENT
    • 7.2.1 HIGHER CONTROL, SECURITY, AND CUSTOMIZATION TO BOLSTER GROWTH
  • 7.3 CLOUD-BASED DEPLOYMENT
    • 7.3.1 NEED TO REDUCE IT OVERHEAD AND ENABLE FASTER INNOVATION TO SPUR GROWTH
  • 7.4 HYBRID DEPLOYMENT
    • 7.4.1 ABILITY TO SUPPORT REAL-TIME INCIDENT REPORTING, ROOT CAUSE ANALYSIS, AND COMPLIANCE MONITORING TO DRIVE MARKET

8 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 HEALTHCARE PROVIDERS
    • 8.2.1 HOSPITALS
      • 8.2.1.1 Rising demand for high-quality care and patient safety to accelerate growth
    • 8.2.2 CLINICS
      • 8.2.2.1 Increasing demand for quality care in outpatient and ambulatory settings to facilitate growth
    • 8.2.3 AMBULATORY CARE CENTERS
      • 8.2.3.1 Growing shift toward outpatient and value-based care models to drive market
    • 8.2.4 LONG-TERM CARE CENTERS
      • 8.2.4.1 Increasing focus on elderly care and patients with chronic conditions to aid growth
    • 8.2.5 PHARMACIES
      • 8.2.5.1 Enhanced medical safety and regulatory compliance to augment growth
    • 8.2.6 OTHER HEALTHCARE PROVIDERS
  • 8.3 PHARMACEUTICAL & BIOTECH COMPANIES
    • 8.3.1 NEED TO MAINTAIN PRODUCT QUALITY, REGULATORY COMPLIANCE, AND PHARMACOVIGILANCE TO ENCOURAGE GROWTH
  • 8.4 HEALTHCARE PAYERS
    • 8.4.1 INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOFTWARE FOR ENHANCED QUALITY ACROSS HEALTHCARE ECOSYSTEM TO AID GROWTH
  • 8.5 MEDTECH COMPANIES
    • 8.5.1 GROWING RISK OF DATA INTEGRITY AND CYBERSECURITY TO FUEL MARKET
  • 8.6 OTHER END USERS

9 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
    • 9.2.2 US
      • 9.2.2.1 Increasing initiatives for improving patient and healthcare workforce safety to aid growth
    • 9.2.3 CANADA
      • 9.2.3.1 Rise in patient safety improvement programs to contribute to growth
  • 9.3 EUROPE
    • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
    • 9.3.2 GERMANY
      • 9.3.2.1 Targeted government policies and push toward modernizing healthcare delivery to propel market
    • 9.3.3 UK
      • 9.3.3.1 Growing initiatives on improving patient outcomes and reducing medical errors to drive market
    • 9.3.4 FRANCE
      • 9.3.4.1 Increasing use of integrated digital platforms in hospitals to expedite growth
    • 9.3.5 ITALY
      • 9.3.5.1 Favorable national legislation and regional healthcare policies to promote growth
    • 9.3.6 SPAIN
      • 9.3.6.1 Rising commitment toward enhanced healthcare quality and culture of safety to aid growth
    • 9.3.7 REST OF EUROPE
  • 9.4 ASIA PACIFIC
    • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
    • 9.4.2 CHINA
      • 9.4.2.1 Increasing deployment of critical incident reporting systems and EHR-linked safety modules to fuel market
    • 9.4.3 JAPAN
      • 9.4.3.1 Growing focus on supporting error reporting, root cause analysis, and clinical protocols to boost market
    • 9.4.4 INDIA
      • 9.4.4.1 Strong public-private sector initiatives to support growth
    • 9.4.5 AUSTRALIA
      • 9.4.5.1 Increasing emphasis on quality improvement across public and private hospitals to spur growth
    • 9.4.6 SOUTH KOREA
      • 9.4.6.1 Innovation-driven healthcare ecosystem to facilitate growth
    • 9.4.7 REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
    • 9.5.2 BRAZIL
      • 9.5.2.1 Increasing focus on reducing adverse events and hospital-acquired infections to encourage growth
    • 9.5.3 MEXICO
      • 9.5.3.1 Expanding healthcare digitization and national policies promoting patient safety to drive market
    • 9.5.4 REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST & AFRICA
    • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
    • 9.6.2 GCC COUNTRIES
      • 9.6.2.1 Saudi Arabia
        • 9.6.2.1.1 Increasing modernization efforts in healthcare to accelerate growth
      • 9.6.2.2 UAE
        • 9.6.2.2.1 Evolving digital health landscape to favor growth
      • 9.6.2.3 Rest of GCC countries
    • 9.6.3 SOUTH AFRICA
      • 9.6.3.1 Increasing awareness about patient safety in public and private healthcare sectors to boost market
    • 9.6.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET
  • 10.3 REVENUE SHARE ANALYSIS, 2020-2024
  • 10.4 MARKET SHARE ANALYSIS, 2024
  • 10.5 BRAND/SOFTWARE COMPARISON
  • 10.6 COMPANY VALUATION AND FINANCIAL METRICS
    • 10.6.1 COMPANY VALUATION
    • 10.6.2 FINANCIAL METRICS
  • 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
    • 10.7.1 STARS
    • 10.7.2 EMERGING LEADERS
    • 10.7.3 PERVASIVE PLAYERS
    • 10.7.4 PARTICIPANTS
    • 10.7.5 COMPANY FOOTPRINT, 2024
      • 10.7.5.1 Company footprint
      • 10.7.5.2 Region footprint
      • 10.7.5.3 Deployment mode footprint
      • 10.7.5.4 Function footprint
      • 10.7.5.5 End-user footprint
  • 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
    • 10.8.1 PROGRESSIVE COMPANIES
    • 10.8.2 RESPONSIVE COMPANIES
    • 10.8.3 DYNAMIC COMPANIES
    • 10.8.4 STARTING BLOCKS
    • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
      • 10.8.5.1 Detailed list of key startups/SMEs
      • 10.8.5.2 Competitive benchmarking of key startups/SMEs
  • 10.9 COMPETITIVE SCENARIO
    • 10.9.1 SOLUTION LAUNCHES AND ENHANCEMENTS
    • 10.9.2 DEALS
    • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

  • 11.1 KEY PLAYERS
    • 11.1.1 RISKONNECT, INC.
      • 11.1.1.1 Business overview
      • 11.1.1.2 Solutions offered
      • 11.1.1.3 Recent developments
        • 11.1.1.3.1 Solution launches and enhancements
        • 11.1.1.3.2 Deals
      • 11.1.1.4 MnM view
        • 11.1.1.4.1 Right to win
        • 11.1.1.4.2 Strategic choices
        • 11.1.1.4.3 Weaknesses and competitive threats
    • 11.1.2 ORIGAMI RISK LLC
      • 11.1.2.1 Business overview
      • 11.1.2.2 Solutions offered
      • 11.1.2.3 Recent developments
        • 11.1.2.3.1 Solution launches and enhancements
      • 11.1.2.4 MnM view
        • 11.1.2.4.1 Right to win
        • 11.1.2.4.2 Strategic choices
        • 11.1.2.4.3 Weaknesses and competitive threats
    • 11.1.3 RLDATIX
      • 11.1.3.1 Business overview
      • 11.1.3.2 Solutions offered
      • 11.1.3.3 Recent developments
        • 11.1.3.3.1 Solution launches and enhancements
        • 11.1.3.3.2 Deals
        • 11.1.3.3.3 Expansions
      • 11.1.3.4 MnM view
        • 11.1.3.4.1 Right to win
        • 11.1.3.4.2 Strategic choices
        • 11.1.3.4.3 Weaknesses and competitive threats
    • 11.1.4 HEALTH CATALYST
      • 11.1.4.1 Business overview
      • 11.1.4.2 Solutions offered
      • 11.1.4.3 Recent developments
        • 11.1.4.3.1 Solution launches and enhancements
        • 11.1.4.3.2 Deals
    • 11.1.5 SYMPLR
      • 11.1.5.1 Business overview
      • 11.1.5.2 Solutions offered
      • 11.1.5.3 Recent developments
        • 11.1.5.3.1 Solution launches and enhancements
        • 11.1.5.3.2 Deals
      • 11.1.5.4 MnM view
        • 11.1.5.4.1 Right to win
        • 11.1.5.4.2 Strategic choices
        • 11.1.5.4.3 Weaknesses and competitive threats
    • 11.1.6 CLARITY GROUP, INC.
      • 11.1.6.1 Business overview
      • 11.1.6.2 Solutions offered
    • 11.1.7 PERFORMANCE HEALTH PARTNERS
      • 11.1.7.1 Business overview
      • 11.1.7.2 Solutions offered
      • 11.1.7.3 Recent developments
        • 11.1.7.3.1 Deals
    • 11.1.8 MORCARE
      • 11.1.8.1 Business overview
      • 11.1.8.2 Solutions offered
    • 11.1.9 RISKQUAL TECHNOLOGIES, INC.
      • 11.1.9.1 Business overview
      • 11.1.9.2 Solutions offered
    • 11.1.10 PRISTA CORPORATION
      • 11.1.10.1 Business overview
      • 11.1.10.2 Solutions offered
    • 11.1.11 SAFEQUAL
      • 11.1.11.1 Business overview
      • 11.1.11.2 Solutions offered
    • 11.1.12 IQVIA
      • 11.1.12.1 Business overview
      • 11.1.12.2 Solutions offered
      • 11.1.12.3 Recent developments
        • 11.1.12.3.1 Solution launches and enhancements
        • 11.1.12.3.2 Deals
    • 11.1.13 INOVALON
      • 11.1.13.1 Business overview
      • 11.1.13.2 Solutions offered
      • 11.1.13.3 Recent developments
        • 11.1.13.3.1 Solution launches and enhancements
    • 11.1.14 NAVEX GLOBAL, INC.
      • 11.1.14.1 Business overview
      • 11.1.14.2 Solutions offered
      • 11.1.14.3 Recent developments
        • 11.1.14.3.1 Solution launches and enhancements
        • 11.1.14.3.2 Deals
        • 11.1.14.3.3 Expansions
    • 11.1.15 CENSINET
      • 11.1.15.1 Business overview
      • 11.1.15.2 Solutions offered
      • 11.1.15.3 Recent developments
        • 11.1.15.3.1 Solution launches and enhancements
    • 11.1.16 AMERICAN DATA NETWORK
      • 11.1.16.1 Business overview
      • 11.1.16.2 Solutions offered
    • 11.1.17 ARVENTA
      • 11.1.17.1 Business overview
      • 11.1.17.2 Solutions offered
    • 11.1.18 COMPLIANCEQUEST
      • 11.1.18.1 Business overview
      • 11.1.18.2 Solutions offered
      • 11.1.18.3 Recent developments
        • 11.1.18.3.1 Solution launches and enhancements
        • 11.1.18.3.2 Deals
    • 11.1.19 RADAR HEALTHCARE INC
      • 11.1.19.1 Business overview
      • 11.1.19.2 Solutions offered
    • 11.1.20 PASCAL METRICS INC.
      • 11.1.20.1 Business overview
      • 11.1.20.2 Solutions offered
  • 11.2 OTHER PLAYERS
    • 11.2.1 OMNIGO
    • 11.2.2 LOGICMANAGER, INC.
    • 11.2.3 DEXUR
    • 11.2.4 HEALTHCARE GRC PTE LTD.
    • 11.2.5 NOSOTECH INC.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
Show more
Product Code: HIT 7318

List of Tables

  • TABLE 1 FACTOR ANALYSIS
  • TABLE 2 PATIENT SAFETY AND RISK SOFTWARE MARKET: RISK ANALYSIS
  • TABLE 3 PATIENT SAFETY AND RISK SOFTWARE MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS
  • TABLE 4 NORTH AMERICA: HEALTHCARE DATA BREACHES, 2021-2025
  • TABLE 5 INDICATIVE PRICING ANALYSIS OF PATIENT SAFETY AND RISK SOFTWARE, BY KEY PLAYER, 2024 (USD)
  • TABLE 6 PATIENT SAFETY AND RISK SOFTWARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM
  • TABLE 7 PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES, JANUARY 2022-SEPTEMBER 2025
  • TABLE 8 PATIENT SAFETY AND RISK SOFTWARE MARKET: LIST OF PATENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 9 PATIENT SAFETY AND RISK SOFTWARE MARKET: KEY CONFERENCES AND EVENTS, 2025-2027
  • TABLE 10 REGULATORY SCENARIO IN NORTH AMERICA
  • TABLE 11 REGULATORY SCENARIO IN EUROPE
  • TABLE 12 REGULATORY SCENARIO IN ASIA PACIFIC
  • TABLE 13 REGULATORY SCENARIO IN MIDDLE EAST & AFRICA
  • TABLE 14 REGULATORY SCENARIO IN LATIN AMERICA
  • TABLE 15 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 16 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 22 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 23 PATIENT SAFETY AND RISK SOFTWARE MARKET: UNMET NEEDS
  • TABLE 24 PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER EXPECTATIONS
  • TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES
  • TABLE 26 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 27 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 28 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 29 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INCIDENT REPORTING SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 30 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 31 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PATIENT LEARNING SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 32 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 33 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 34 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK/COMPLIANCE MONITORING & ANALYTICS SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 35 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 36 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 37 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 38 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 39 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR INFECTION CONTROL SYSTEMS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 40 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 41 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 42 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLAIMS MANAGEMENT SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 43 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 44 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 45 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR ON-PREMISE DEPLOYMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 46 PATIENT SAFETY & RISK SOFTWARE MARKET FOR CLOUD-BASED DEPLOYMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 47 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HYBRID DEPLOYMENT, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 48 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 49 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 50 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 51 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HOSPITALS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 52 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 53 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 54 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR LONG-TERM CARE CENTERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 55 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 56 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER HEALTHCARE PROVIDERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 57 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 58 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PAYERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 59 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR MEDTECH COMPANIES, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 60 PATIENT SAFETY AND RISK SOFTWARE MARKET FOR OTHER END USERS, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 61 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION, 2023-2030 (USD MILLION)
  • TABLE 62 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 63 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 64 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 65 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 66 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 67 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 68 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 69 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 70 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 71 KEY ACTIVITIES IN US PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET
  • TABLE 72 US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 73 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 74 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 75 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 76 US: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 77 US: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 78 US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 79 US: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 80 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET, BY FUNCTION, 2023-2030(USD MILLION)
  • TABLE 81 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 82 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 83 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 84 CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 85 CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 86 CANADA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030(USD MILLION)
  • TABLE 87 CANADA: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 88 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023-2030(USD MILLION)
  • TABLE 89 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030(USD MILLION)
  • TABLE 90 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 91 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 92 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 93 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 94 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 95 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030(USD MILLION)
  • TABLE 96 EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 97 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030(USD MILLION)
  • TABLE 98 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030(USD MILLION)
  • TABLE 99 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 100 GERMANY: PATIENT SAFETY AND RISK MANAGEMENT SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 101 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 102 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 103 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 104 GERMANY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 105 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 106 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 107 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 108 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 109 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 110 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 111 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 112 UK: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 113 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 114 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 115 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 116 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 117 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 118 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 119 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 120 FRANCE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 121 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 122 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 123 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 124 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 125 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 126 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 127 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 128 ITALY: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 129 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 130 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 131 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 132 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 133 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 134 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 135 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 136 SPAIN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 137 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 138 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 139 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 140 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 141 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 142 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 143 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 144 REST OF EUROPE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 146 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 147 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 148 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 149 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 150 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 151 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 153 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 154 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 155 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 156 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 157 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 158 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 159 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 160 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 161 CHINA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 162 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 163 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 164 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 165 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 166 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 167 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 168 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 169 JAPAN: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 170 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 171 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 172 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 173 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 174 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 175 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 176 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 177 INDIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 178 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 179 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 180 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 181 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 182 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 183 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 184 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 185 AUSTRALIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 186 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 187 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 188 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 189 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 190 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 191 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 192 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 193 SOUTH KOREA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 194 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 195 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 196 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 197 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 198 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 199 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 200 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 201 REST OF ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 202 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 203 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 204 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 205 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 206 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 207 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 208 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 209 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 210 LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 211 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 212 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 213 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 214 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 215 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 216 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 217 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 218 BRAZIL: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 219 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 220 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 221 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 222 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 223 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 224 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 225 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 226 MEXICO: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 227 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 228 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 229 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 230 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 231 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 232 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 233 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 234 REST OF LATIN AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 235 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 236 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 237 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 238 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 239 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 240 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 241 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 242 MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 243 MIDDLE EAST AND AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 244 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY COUNTRY, 2023-2030 (USD MILLION)
  • TABLE 245 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 246 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 247 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 249 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 250 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 251 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 252 GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 253 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 254 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 255 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 256 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 257 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 258 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 259 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 260 SAUDI ARABIA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 261 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 262 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK AND SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 263 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 264 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 265 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 266 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 267 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 268 UAE: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 269 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 270 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 271 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 272 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 273 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 274 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 275 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 276 REST OF GCC COUNTRIES: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 277 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 278 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 279 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 280 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 281 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL & LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 282 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 283 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 284 SOUTH AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 285 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2023-2030 (USD MILLION)
  • TABLE 286 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR RISK & SAFETY MANAGEMENT, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 287 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR COMPLIANCE & GOVERNANCE, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 288 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR CLINICAL SAFETY CONTROLS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 289 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR FINANCIAL AND LEGAL RISK HANDLING, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 290 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2023-2030 (USD MILLION)
  • TABLE 291 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2023-2030 (USD MILLION)
  • TABLE 292 REST OF MIDDLE EAST & AFRICA: PATIENT SAFETY AND RISK SOFTWARE MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2023-2030 (USD MILLION)
  • TABLE 293 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, JANUARY 2022-SEPTEMBER 2025
  • TABLE 294 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEGREE OF COMPETITION
  • TABLE 295 PATIENT SAFETY AND RISK SOFTWARE MARKET: REGION FOOTPRINT
  • TABLE 296 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEPLOYMENT MODE FOOTPRINT
  • TABLE 297 PATIENT SAFETY AND RISK SOFTWARE MARKET: FUNCTION FOOTPRINT
  • TABLE 298 PATIENT SAFETY AND RISK SOFTWARE MARKET: END-USER FOOTPRINT
  • TABLE 299 PATIENT SAFETY AND RISK SOFTWARE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 300 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 301 PATIENT SAFETY AND RISK SOFTWARE MARKET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 302 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 303 PATIENT SAFETY AND RISK SOFTWARE MARKET: EXPANSIONS, JANUARY 2022-AUGUST 2025
  • TABLE 304 RISKONNECT, INC.: COMPANY OVERVIEW
  • TABLE 305 RISKONNECT, INC.: SOLUTIONS OFFERED
  • TABLE 306 RISKONNECT, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 307 RISKONNECT, INC.: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 308 ORIGAMI RISK LLC: COMPANY OVERVIEW
  • TABLE 309 ORIGAMI RISK LLC: SOLUTIONS OFFERED
  • TABLE 310 ORIGAMI RISK LLC: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 311 RLDATIX: COMPANY OVERVIEW
  • TABLE 312 RLDATIX: SOLUTIONS OFFERED
  • TABLE 313 RLDATIX: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 314 RLDATIX: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 315 RLDATIX: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 316 HEALTH CATALYST: COMPANY OVERVIEW
  • TABLE 317 HEALTH CATALYST: SOLUTIONS OFFERED
  • TABLE 318 HEALTH CATALYST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 319 HEALTH CATALYST: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 320 SYMPLR: COMPANY OVERVIEW
  • TABLE 321 SYMPLR: SOLUTIONS OFFERED
  • TABLE 322 SYMPLR: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 323 SYMPLR: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 324 CLARITY GROUP, INC.: COMPANY OVERVIEW
  • TABLE 325 CLARITY GROUP, INC.: SOLUTIONS OFFERED
  • TABLE 326 PERFORMANCE HEALTH PARTNERS: COMPANY OVERVIEW
  • TABLE 327 PERFORMANCE HEALTH PARTNERS: SOLUTIONS OFFERED
  • TABLE 328 PERFORMANCE HEALTH PARTNERS: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 329 MORCARE: COMPANY OVERVIEW
  • TABLE 330 MORCARE: SOLUTIONS OFFERED
  • TABLE 331 RISKQUAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
  • TABLE 332 RISKQUAL TECHNOLOGIES, INC.: SOLUTIONS OFFERED
  • TABLE 333 PRISTA CORPORATION: COMPANY OVERVIEW
  • TABLE 334 PRISTA CORPORATION: SOLUTIONS OFFERED
  • TABLE 335 SAFEQUAL: COMPANY OVERVIEW
  • TABLE 336 SAFEQUAL: SOLUTIONS OFFERED
  • TABLE 337 IQVIA: COMPANY OVERVIEW
  • TABLE 338 IQVIA: SOLUTIONS OFFERED
  • TABLE 339 IQVIA: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 340 IQVIA: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 341 INOVALON: COMPANY OVERVIEW
  • TABLE 342 INOVALON: SOLUTIONS OFFERED
  • TABLE 343 INOVALON: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 344 NAVEX GLOBAL, INC.: COMPANY OVERVIEW
  • TABLE 345 NAVEX GLOBAL, INC.: SOLUTIONS OFFERED
  • TABLE 346 NAVEX GLOBAL, INC.: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 347 NAVEX GLOBAL, INC.: DEALS, JANUARY 2022-SEPTEMBER 2024
  • TABLE 348 NAVEX GLOBAL, INC.: EXPANSIONS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 349 CENSINET: COMPANY OVERVIEW
  • TABLE 350 CENSINET: SOLUTIONS OFFERED
  • TABLE 351 CENSINET: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 352 AMERICAN DATA NETWORK: COMPANY OVERVIEW
  • TABLE 353 AMERICAN DATA NETWORK: SOLUTIONS OFFERED
  • TABLE 354 ARVENTA: COMPANY OVERVIEW
  • TABLE 355 ARVENTA: SOLUTIONS OFFERED
  • TABLE 356 COMPLIANCEQUEST: COMPANY OVERVIEW
  • TABLE 357 COMPLIANCEQUEST: SOLUTIONS OFFERED
  • TABLE 358 COMPLIANCEQUEST: SOLUTION LAUNCHES AND ENHANCEMENTS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 359 COMPLIANCEQUEST: DEALS, JANUARY 2022-SEPTEMBER 2025
  • TABLE 360 RADAR HEALTHCARE INC: COMPANY OVERVIEW
  • TABLE 361 RADAR HEALTHCARE INC: SOLUTIONS OFFERED
  • TABLE 362 PASCAL METRICS INC.: COMPANY OVERVIEW
  • TABLE 363 PASCAL METRICS INC.: SOLUTIONS OFFERED
  • TABLE 364 OMNIGO: COMPANY OVERVIEW
  • TABLE 365 LOGICMANAGER, INC.: COMPANY OVERVIEW
  • TABLE 366 DEXUR: COMPANY OVERVIEW
  • TABLE 367 HEALTHCARE GRC PTE. LTD.: COMPANY OVERVIEW
  • TABLE 368 NOSOTECH INC.: COMPANY OVERVIEW

List of Figures

  • FIGURE 1 PATIENT SAFETY AND RISK SOFTWARE MARKET SEGMENTATION AND REGIONAL SCOPE
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 PRIMARY SOURCES
  • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND-SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 5 SUPPLY-SIDE MARKET ESTIMATION
  • FIGURE 6 PATIENT SAFETY AND RISK SOFTWARE MARKET: REVENUE ESTIMATION APPROACH
  • FIGURE 7 BOTTOM-UP APPROACH: END-USER SPENDING ON PATIENT SAFETY AND RISK SOFTWARE
  • FIGURE 8 CAGR PROJECTIONS FROM MARKET DYNAMICS, 2025-2030
  • FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
  • FIGURE 10 TOP-DOWN APPROACH
  • FIGURE 11 DATA TRIANGULATION METHODOLOGY
  • FIGURE 12 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION, 2025 VS. 2030 (USD MILLION)
  • FIGURE 13 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE, 2025 VS. 2030 (USD MILLION)
  • FIGURE 14 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION)
  • FIGURE 15 PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHICAL SNAPSHOT
  • FIGURE 16 GROWING HEALTHCARE EXPENDITURE AND RISING ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET
  • FIGURE 17 HEALTHCARE PROVIDERS AND US LED NORTH AMERICAN MARKET IN 2024
  • FIGURE 18 INDIA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 19 EMERGING MARKETS TO HAVE HIGHER GROWTH THAN DEVELOPED MARKETS DURING FORECAST PERIOD
  • FIGURE 20 PATIENT SAFETY AND RISK SOFTWARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 21 REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY HOSPITALS, 2022-2024
  • FIGURE 22 REPORTS SUBMITTED TO PENNSYLVANIA'S PATIENT SAFETY REPORTING SYSTEM BY NON-HOSPITALS, 2022-2024
  • FIGURE 23 REVENUE SHIFT IN PATIENT SAFETY AND RISK SOFTWARE MARKET
  • FIGURE 24 PATIENT SAFETY AND RISK SOFTWARE MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 25 PATIENT SAFETY AND RISK SOFTWARE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 26 PATIENT SAFETY AND RISK SOFTWARE MARKET: INVESTMENT AND FUNDING SCENARIO
  • FIGURE 27 PATIENT SAFETY AND RISK SOFTWARE MARKET: JURISDICTION AND TOP APPLICANT ANALYSIS, JANUARY 2022-SEPTEMBER 2025
  • FIGURE 28 PATIENT SAFETY AND RISK SOFTWARE MARKET: PATENT ANALYSIS, JANUARY 2015-SEPTEMBER 2025
  • FIGURE 29 PATIENT SAFETY AND RISK SOFTWARE MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF TOP THREE END USERS
  • FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 32 MARKET POTENTIAL OF AI/GENERATIVE AI IN PATIENT SAFETY AND RISK SOFTWARE
  • FIGURE 33 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS
  • FIGURE 34 NORTH AMERICA: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT
  • FIGURE 35 ASIA PACIFIC: PATIENT SAFETY AND RISK SOFTWARE MARKET SNAPSHOT
  • FIGURE 36 REVENUE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2020-2024 (USD MILLION)
  • FIGURE 37 MARKET SHARE ANALYSIS OF KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET, 2024
  • FIGURE 38 PATIENT SAFETY AND RISK SOFTWARE MARKET: BRAND/SOFTWARE COMPARISON
  • FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 40 EV/EBITDA OF KEY VENDORS
  • FIGURE 41 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024
  • FIGURE 42 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY FOOTPRINT
  • FIGURE 43 PATIENT SAFETY AND RISK SOFTWARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024
  • FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2024)
  • FIGURE 45 IQVIA: COMPANY SNAPSHOT (2024)
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!